Establishment of HPLC fingerprint of Huangqi Shengmai Decoction and determination of multi-component contents

Through HPLC method and stoichiometric analysis, the fingerprint map and component content determination method of Astragalus Shengmai Drink were established, which solved the problem of incomplete evaluation of Astragalus Shengmai Drink in the existing technology, and achieved accurate determination of its main components. and quality control.

CN117949565BActive Publication Date: 2024-12-03LANZHOU FOOD & DRUG INSPECTION & TESTING INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410128632.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-30
Publication Date
2024-12-03
Estimated Expiration
2044-01-30

AI Technical Summary

Technical Problem

The existing technology has failed to effectively conduct a comprehensive quality evaluation of the Astragalus Shengmai Drink, lacks qualitative and quantitative research on its main components, and cannot reflect the quality of the Chinese medicine compound preparation as a whole, affecting clinical efficacy and quality control.

Method used

The fingerprint map of Astragalus Shengmai Drink was established by HPLC method, and combined with stoichiometric analysis methods, the mutton isoflavone glucoside, Codonopsis alkynin, Mnarol isoflavone, Mnarol isoflavone, Mnarol, Schisandra chinensis alkynin, Mnarol, Schisandra chinensis alkynin, Mnarol The content of the test conditions are optimized to achieve accurate quality evaluation.

Benefits of technology

Through HPLC detection method, the chemical composition resolution and accuracy of Astragalus Shengmai Drink is achieved, providing a basis for quality control of Astragalus Shengmai Drink, which can fully reflect its chemical information and improve the quality control level.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117949565B_ABST
    Figure CN117949565B_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of drug component content determination, and specifically to a method for establishing an HPLC fingerprint of Huangqi Shengmai Drink and the fingerprint thereof, wherein the method comprises the following steps: S1, preparation of a reference solution; S2, preparation of a test solution; S3, content determination: adopting an HPLC method to obtain a reference chromatogram of the reference solution and a test chromatogram of the test solution respectively under the same chromatographic conditions; the method of the invention has good separation of various components, and in a negative chromatogram, each chromatographic peak only appears in the corresponding sample; each component has good correlation within its own interval; the instrument has good precision, repeatability and stability, indicating that the method is good; an HPLC fingerprint of Huangqi Shengmai Drink is established, which has strong specificity, is accurate and reliable, and the pretreatment of the test solution is simple, so as to provide a reference basis for comprehensive evaluation of the effective quality control of Huangqi Shengmai Drink and can be used to control the quality of Huangqi Shengmai Drink.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug component content determination, and in particular to an HPLC fingerprint establishment and multi-component content determination method of Huangqi Shengmai Decoction. Background Art

[0002] Compared with chemical drugs, Chinese medicine and Chinese patent medicine are safer and have fewer side effects, but due to their complex chemical composition, the quality is difficult to control and affects the clinical efficacy. Huangqi Shengmai Yin is a Chinese medicine compound preparation composed of five medicinal materials: Astragalus, Codonopsis, Ophiopogon, Schisandra, and Schisandra. It has the functions of strengthening qi and nourishing yin, nourishing the heart and lungs, and is used for coronary heart disease with qi and yin deficiency, palpitations and shortness of breath. [1] In the formula, Codonopsis pilosula and Astragalus membranaceus are the main and auxiliary drugs, and their combination is often used to treat symptoms such as spleen and stomach qi deficiency, asthenia, and spontaneous sweating. Schisandra chinensis and Ophiopogon japonicus are adjuvants and guiding drugs, which have the effects of nourishing the kidney and calming the mind, clearing the heart and eliminating troubles. Their combination is used in Tianwang Buxin Pills [2] , Dashudi Pills, etc. Its quality standards are included in the "Pharmaceutical Standards of the Ministry of Health of the People's Republic of China" Chinese Medicine Formula Preparations (Volume 16). The inspection items include the determination of the relative density, pH value, and citric acid content of Huangqi Shengmai Yin, but there is no qualitative and quantitative research on other active ingredients, and it is impossible to reflect the quality of the preparation as a whole. Therefore, it is necessary to clarify the drug substance basis of the compound preparation and improve the quality control level.

[0003] Chemometrics mainly includes cluster analysis, principal component analysis, orthogonal partial least squares discriminant analysis, etc. It is an important method for screening quality markers of traditional Chinese medicine. [3-5] In recent years, experimental research on Huangqi Shengmai Yin has focused on pharmacology, efficacy, clinical application, etc. [6-7] There is no research on the fingerprint of the main active ingredients, and there is little content in the literature on content determination, mainly focusing on astragaloside IV. [8] and polysaccharides [9] Ingredients. After searching, it was found that the invention patent CN117147722A discloses the application of a biosensor combined with UPLC-MS technology in the identification of the key quality attributes of the nature and taste of traditional Chinese medicine, and the key quality attributes of the nature and taste of Huangqi Shengmai Yin and Jianwei Xiaoshi Tablets were identified, providing a reference for the identification of key quality attributes of other traditional Chinese medicines. However, no researchers have studied the comprehensive quality evaluation of Huangqi Shengmai Yin.

[0004] This invention combines the new concept and core theory of traditional Chinese medicine Q-Marker proposed by Academician Liu Changxiao [10-11]Based on the above research, the fingerprint of Huangqi Shengmai Drink and the content determination method of calycosin glucoside, codonopsis pilosula, formononetin, calycosin, formononetin, schisandrin A and schisandrin B were established by HPLC, and chemometric analysis was carried out for the comprehensive quality evaluation of Huangqi Shengmai Drink.

[0005] References

[0006] [1] Jiang Jiangang, Du Xiaoma, Yao Yumei, et al. Effects of Huangqi Shengmai Yin on cardiac function, immune function and peripheral blood miRNA-155 expression in patients with coronary heart disease and heart failure[J]. Cardiology and Circulation, 2021, 40(03): 262-266.

[0007] [2] Shen Danping, Jiang Peng, Zhan Changsen. Study on quality control of Tianwangbuxin Pills based on UPLC fingerprint and multi-component determination [J / OL]. Chinese Journal of Traditional Chinese Medicine: 1-13 [2023-12-12].

[0008] [3] Qu Binqing, Liu Longji, Yang Jingxiao, et al. Evaluation of the quality of Citrus aurantium from different origins by UPLC combined with grey correlation analysis and chemometrics[J]. Chinese Traditional Patent Medicine, 2023, 45(11): 3663-3670.

[0009] [4] Luan Yongfu, Xie Yingying, Zhou Guangtao, et al. Multi-index content determination and chemometric analysis of ginseng Jianpi pills[J]. Chinese Herbal Medicine, 2023, 54(21): 7044-7054.

[0010] [5] Han Zhaofeng, Yu Yan, Han Yu, et al. Study on quality evaluation of Liaoning authentic medicinal material Schisandra chinensis based on chemometrics and fingerprint [J / OL]. Chinese Journal of Traditional Chinese Medicine: 1-14 [2023-12-13].

[0011] [6] Yuan Yahui, Yuan Rong, Miao Yu, et al. Effects of Huangqi Shengmai Yin on a rat model of fatigue combined with myocardial injury and its related mechanisms[J]. China Journal of Traditional Chinese Medicine, 2022, 47(19): 5292-5298.

[0012] [7] Wei Yuna, Mo Xuemei, Wang Qiang, et al. Clinical efficacy of Huangqi Guizhi Wuwu Decoction combined with Shengmaiyin in the treatment of cardiac function in diabetic cardiomyopathy[J]. Chinese Journal of Experimental Traditional Chinese Medicine, 2021, 27(19): 104-109.

[0013] [8] Guan Danli, Tan Hantian, Liu Yundi. Analysis of astragaloside content in Huangqi Shengmai Yin[J]. Chinese Journal of Disability Medicine, 2012, 20(06):93+129.

[0014] [9] Hou Xiaorong, Ren Liqin, Qiu Feijun, et al. Study on the monosaccharide fingerprint of polysaccharide hydrolysis in Huangqi Shengmai Yin[J]. Journal of Zhejiang University of Technology, 2020, 48(03): 300-306.

[0015]

[10] Yang Changming, Yang Ping, Liu Lehuan, et al. Research progress of quality markers (Q-Markers) of traditional Chinese medicine and thoughts on the quality research of traditional Chinese medicine [J]. Chinese Herbal Medicine, 2021, 52(09): 2519-2526.

[0016]

[11] Zhang Tiejun, Bai Gang, Chen Changqing, et al. Research path of quality markers (Q-markers) for compound traditional Chinese medicine based on the “five principles”[J]. Chinese Herbal Medicine, 2018, 49(01): 1-13. Summary of the invention

[0017] The object of the present invention is to provide an HPLC detection method for Huangqi Shengmai Yin, wherein Huangqi Shengmai Yin is subjected to appropriate extraction to obtain a test solution, which is then tested using HPLC; the HPLC test conditions are:

[0018] Column: CAPCELLPAK C 18 MG column, 250 mm × 4.6 mm, 5 μm;

[0019] Mobile phase: Phase A is 90% acetonitrile or acetonitrile, phase B is 0.1% phosphoric acid aqueous solution or 0.1% glacial acetic acid aqueous solution, gradient elution; flow rate: 0.8 mL min -1 ;

[0020] Column temperature: 30°C;

[0021] Detection wavelength 203~280nm;

[0022] Injection volume: 10 μL;

[0023] The specific process of gradient elution is as follows: 0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A.

[0024] Preferably, the mobile phase: phase A is 90% acetonitrile or acetonitrile, and phase B is 0.1% phosphoric acid aqueous solution.

[0025] Preferably, the detection wavelength is 250 nm.

[0026] The second object of the present invention is to provide a method for establishing the HPLC fingerprint of Huangqi Shengmai Yin, wherein the method comprises the following steps:

[0027] S1. Preparation of reference substance solution: accurately weigh each reference substance, place it in a volumetric flask, dissolve it with methanol, and make up to volume to obtain a reference substance solution containing a predetermined concentration of a standard component;

[0028] S2. Preparation of test solution: accurately measure the sample, mix it with the extraction solvent at an extraction ratio of 1:0.5-2, perform ultrasonic extraction, let it stand and cool, filter, and take the filtrate to obtain the solution;

[0029] S3, content determination: adopt the HPLC detection method to obtain the reference chromatogram of the reference solution and the test chromatogram of the test solution under the same chromatographic conditions;

[0030] The standard components described in step S1 are calycosin glucoside, codonopsis pilosula, formononetin, calycosin, formononetin, schisandrae alcohol A and schisandrae alcohol B.

[0031] Preferably, the extraction solvent in step S2 is 30% methanol, 50% methanol, 70% methanol, methanol, 95% ethanol or water.

[0032] Preferably, the extraction solvent in step S2 is methanol.

[0033] Preferably, the extraction ratio of the test solution to the extraction solvent described in step S2 is 1:1.

[0034] Preferably, the filtration in step S2 uses a 0.45 μm microporous filter membrane.

[0035] The third object of the present invention is to provide the application of the method for establishing the HPLC fingerprint of Huangqi Shengmai Yin in detecting and identifying Huangqi Shengmai Yin.

[0036] The fourth object of the present invention is to provide a fingerprint obtained by the method for establishing the HPLC fingerprint of Huangqi Shengmai Yin.

[0037] The beneficial effects of the present invention are:

[0038] (1) The present invention provides an HPLC detection method for Huangqi Shengmai Yin. Through repeated exploration combined with saving time and reagent costs, 250 nm is finally determined as the detection wavelength, the mobile phase is acetonitrile-water (containing 0.1% phosphoric acid) gradient elution for 117 min, and the extraction method is ultrasonic extraction of sample and water in a ratio of 1:1 for 30 min. When the extraction conditions are as follows, the chromatographic peaks of each component have better peak shapes and stable peak elution time, which can more comprehensively and accurately reflect the chemical information of Huangqi Shengmai Yin.

[0039] (2) Specificity test: The components are well separated. In the negative chromatogram, each chromatographic peak only appears in the corresponding sample;

[0040] Linear relationship: Each component has a good correlation within its own interval;

[0041] Precision test: After 6 consecutive injections, the RSDs of the peak areas of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A and schisandrin B were 1.71%, 0.05%, 0.36%, 0.31%, 0.23%, 0.18% and 0.23%, respectively, indicating that the instrument had good precision.

[0042] Repeatability: Six test solutions were prepared in parallel, and the peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A, and schisandrin B were 0.21%, 2.52%, 2.12%, 1.84%, 2.78%, 0.84%, and 1.99%, respectively, and the average contents were 11.4508, 2.6211, 3.6856, 0.7202, 13.2208, 13.3957, and 2.6682 μg mL -1 , indicating that the method has good repeatability;

[0043] Stability test: The samples were injected and measured at 0, 2, 4, 8, 12 and 24 hours respectively, and the peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A and schisandrin B were 0.29%, 1.11%, 2.15%, 2.54%, 1.54%, 0.23% and 1.94% respectively, indicating that the test solution had good stability within 24 hours;

[0044] Sample recovery test: The average recoveries of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrae alcohol A and schisandrae alcohol B were 99.47%, 105.43%, 95.17%, 103.50%, 94.10%, 92.57% and 96.78%, respectively, and the RSDs were 2.59%, 2.50%, 3.19%, 2.93%, 2.94%, 2.00% and 3.15%, respectively.

[0045] (3) The results of the present invention showed that in the fingerprint evaluation of 20 batches of Huangqi Shengmai Yin, the similarity was between 0.896 and 0.999, indicating that the chemical composition of each batch of Huangqi Shengmai Yin was relatively similar, but there were certain differences in the content of each component, which required further analysis and verification. In the cluster analysis, Huangqi Shengmai Yin was divided into 4 categories, with samples from manufacturer S2 clustered into the first category, 11 batches of samples from manufacturer S1 clustered into the second category, and the remaining 2 batches of samples were clustered into the third and fourth categories respectively. A total of 5 principal components were extracted by principal component analysis, with a cumulative variance contribution rate of 90.367%. The partial least squares discriminant analysis results showed that there were 9 common peaks with VIP values ​​greater than 1, and these components may be differential components that affect the quality of Huangqi Shengmai Yin.

[0046] (4) The present invention establishes an HPLC fingerprint of Huangqi Shengmai Yin, which is highly specific, accurate and reliable, and the pretreatment of the test solution is simple. According to the principle of "component measurability" of Q-Marker, it provides a reference basis for the comprehensive evaluation of the effective quality control of Huangqi Shengmai Yin, and can be used to control the quality of Huangqi Shengmai Yin. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 Chromatograms of different gradient elution methods

[0048] Note: Chromatograms of gradient elution methods (1), (2), and (3) from top to bottom

[0049] Figure 2 Chromatograms of different mobile phase systems Note: The mobile phase systems from top to bottom are 90% acetonitrile-water (containing 0.1% phosphoric acid), acetonitrile-water (containing 0.1% phosphoric acid), acetonitrile-water (containing 0.1% glacial acetic acid)

[0050] Figure 3 Chromatograms of different extraction solvents Note: The extraction solvents from top to bottom are 30% methanol, 50% methanol, 70% methanol, 100% methanol, 95% ethanol and water.

[0051] Figure 4 Chromatograms of different extraction ratios Note: From top to bottom, the extraction ratios are sample: water 1:0.5, sample: water 1:1, and sample: water 1:2. Figure 5 Chromatograms at different measurement wavelengths

[0052] Note: The measurement wavelengths from top to bottom are 203nm, 250nm, and 280nm.

[0053] Figure 6 HPLC fingerprint of Huangqi Shengmai Yin Note: 12. Calycosin glucoside 14. Codonopsis pilosula glycoside 15. Formononetin 16. Calycosin glucoside 17. Formononetin 18. Schisandrin A 19. Schisandrin B

[0054] Figure 7 Cluster analysis of 20 batches of Huangqi Shengmai Yin

[0055] Figure 8 Gravel Chart

[0056] Fig. 9 OPLS-DA score plot of 20 batches of samples

[0057] Fig.10 VIP value of common peak

[0058] Fig.11 Notes for HPLC chromatograms of each component: 1. Calycosin glucoside 2. Codonopsis pilosula 3. Formononetin 4. Calycosin 5. Formononetin 6. Schisandrin A 7. Schisandrin B;

[0059] C. Negative samples (a-f are respectively lacking Astragalus, Codonopsis, Schisandrae Chinensis, Schisandrae Chinensis, Astragalus, Codonopsis, Schisandrae Chinensis, Schisandrae Chinensis, and Schisandrae Chinensis) DETAILED DESCRIPTION

[0060] In order to make the purpose, technical solution and effect of the present invention clearer and more specific, the present invention is further described in detail with reference to the accompanying drawings and examples. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0061] In the following examples, unless otherwise specified, all reagents are commercially available.

[0062] In the following examples, unless otherwise specified, the methods used are all conventional methods.

[0063] Example 1: Optimization of HPLC detection method for Huangqi Shengmai Yin

[0064] 1 Materials

[0065] 1.1 Instrument

[0066] Agilent 1260 Infinity II high performance liquid chromatograph (Agilent, USA); Mettler XSE205DU 1 / 100000 electronic balance (Mettler-Toledo, Switzerland); SBL-10DT ultrasonic constant temperature cleaning machine (Ningbo Xinzhi Biotechnology Co., Ltd.).

[0067] 1.2 Reagents and drugs

[0068] Reference substances, calycosin glucoside (batch number 15367, purity 96.8%), codonopsis ginsenoside (batch number 16550, purity 98.0%), formononetin (batch number 15943, purity 98.0%), calycosin (batch number 15986, purity 99.5%), formononetin (batch number 16353, purity 97.2%), schisandrae alcohol A (batch number 16163, purity 99.9%), schisandrae alcohol B (batch number 12567, purity 98.0%) were purchased from Shanghai Shidande Biotechnology Co., Ltd. 20 batches of Huangqi Shengmai Yin, numbered Y1 to Y20, see Table 1 for details. Acetonitrile and methanol were chromatographically pure, Watsons purified water, and other reagents were analytically pure.

[0069] Table 1 Sample information

[0070]

[0071] 2. Preparation of test solution

[0072] Accurately measure the sample (Y9) and mix it with the extraction solvent in a ratio of 0.5 to 2:1, perform ultrasonic extraction for 30 minutes, let it stand and cool, filter it through a 0.45 μm microporous filter membrane, and obtain the filtrate.

[0073] 3. Optimization of Chromatographic Conditions

[0074] 3.1 Selection of gradient elution method

[0075] (1) Chromatographic conditions CAPCELLPAK C 18 MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-8 min, 2%-15% A; 8-25 min, 15%-44% A; 25-35 min, 44%-50% A; 35-40 min, 50% A-65% A; 40-45 min, 65%-79% A; 45-50 min, 79%-90% A; 50-55 min, 90%-98% A; 55-56 min, 98%-65% A; 56-57 min, 65%-2% A; 57-58 min, 2% A); flow rate: 1 mL min -1 ; Column temperature 35℃; Detection wavelength 250nm; Injection volume 10μL.

[0076] (2) Chromatographic conditions CAPCELLPAK C 18MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% glacial acetic acid water (B), gradient elution (0-5 min, 3%-7% A; 5-13 min, 7%-10% A; 13-20 min, 10%-25% A; 20-29 min, 25% A-30% A; 29-40 min, 30%-60% A; 40-47 min, 60%-90% A; 47-49 min, 90%-3% A; 49-50 min, 3% A); flow rate: 1 mL min -1 ; Column temperature 35°C; Detection wavelength 250nm; Injection volume 10μL. (3) Chromatographic conditions CAPCELLPAK C 18 MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid water (B), gradient elution (0-5 min, 3%-7% A; 5-10 min, 7%-10% A; 10-18 min, 10%-21% A; 18-20 min, 21% A-22% A; 20-22 min, 22%-23% A; 22-25 min, 23%-24% A ;25~30min, 24%~26%A; 30~35min, 26%~28%A; 35~42min, 28%~40%A; 42~46min, 40%~60%A; 46 ~52min, 60%~80%A; 52~58min, 80%~91%A; 58~59min, 91%~3%A; 59~60min, 3%A); flow rate 0.8mL·min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0077] (4) Chromatographic conditions: CAPCELLPAK C 18 MG column (250 mm × 4.6 mm, 5 μm); acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), gradient elution program (0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A); flow rate 0.8 mL min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0078] Preparation of test solution: Prepare in the same manner as in item “2.2”.

[0079] like Figure 1 As shown, the chromatographic method of (1) failed to effectively separate the components in the test sample. The chromatographic peaks were dense in the first 20 minutes, and the number of chromatographic peaks was small after 20 minutes. The gradient elution conditions needed to be readjusted. The chromatographic method of (2) was affected by the composition of the mobile phase, flow rate, gradient elution, and changes in the polarity of the mobile phase. At the retention time of 17 to 25 minutes, the baseline of the chromatogram fluctuated greatly, and the chromatographic peak separation was poor. The method of (3) replaced acetonitrile (A)-0.1% phosphoric acid water (B) as the mobile phase, and at the same time reduced the flow rate and column temperature. The baseline of the chromatogram was straighter than before, but the elution conditions still needed to be further adjusted. The overall chromatographic behavior was further improved under the method of (4), and the separation effect was good.

[0080] 3.2 Optimization of different mobile phase systems

[0081] Chromatographic conditions: CAPCELLPAK C 18 MG chromatographic column (250mm×4.6mm, 5μm); the chromatographic behaviors of three different mobile phase systems, 90% acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), and acetonitrile (A)-0.1% glacial acetic acid aqueous solution (B), were investigated respectively. The gradient elution program (0-10min, 3% A; 10-20min, 3%-6% A; 20-30min, 6%-12% A; 30- 36min, 12%A~16%A; 36~56min, 16%~21%A; 56~76min, 21%~27%A; 76~87min, 27%~37%A; 87~97min, 37%~60%A; 97~105min, 60%~79%A; 105~113min, 79%~91%A; 113~117min, 91%~1%A); flow rate 0.8mL·min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0082] Preparation of test solution: Prepare as in item "2".

[0083] Figure 2 It can be seen that when the mobile phase is acetonitrile-water (containing 0.1% phosphoric acid), the chromatographic peak shape is better, the separation is good, and the baseline is relatively straight. When the mobile phase is 90% acetonitrile-water (containing 0.1% phosphoric acid), the solvent peak response value is too large and there is a certain interference.

[0084] 3.3 Optimization of different extraction solvents

[0085] Chromatographic conditions: CAPCELLPAK C 18MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), gradient elution (0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A); flow rate: 0.8 mL min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0086] Preparation of test solution: Accurately measure 6 portions of sample (Y9), 2 mL each, and mix them with 30% methanol, 50% methanol, 70% methanol, methanol, 95% ethanol and water in a ratio of 1:1. Ultrasonic extraction was performed for 30 min. The solution was allowed to stand and cool, filtered through a 0.45 μm microporous filter membrane, and the filtrate was obtained.

[0087] As shown in Table 2, when 30%, 50% and 70% methanol were used for extraction, the contents of calycosin and formononetin were relatively low, while the contents of other components were not much different. Figure 3 It can be seen that when 50% methanol, 70% methanol, 100% methanol, and 95% ethanol were extracted, the solvent peaks were too high and interfered with the chromatographic peaks. In summary, combined with environmental friendliness and reagent costs, water was finally selected as the best extraction solvent.

[0088] Table 2 Content of each component under different extraction solvents (μg / mL)

[0089]

[0090] 3.4 Chromatograms of different extraction ratios

[0091] Chromatographic conditions: CAPCELLPAK C 18MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), gradient elution (0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A); flow rate: 0.8 mL min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0092] Preparation of test solution: accurately measure 3 portions of sample (Y9), 2 mL each, mix the sample with water at a ratio of 1:0.5, 1:1, and 1:2, respectively, perform ultrasonic extraction for 30 min, let stand and cool, filter through a 0.45 μm microporous filter membrane, and obtain the filtrate.

[0093] From Table 3 and Figure 4 It can be seen that the content of each component is not much different under different extraction ratios. Considering the time saving and reagent cost, the sample and water ratio of 1:1 is selected for extraction and injection.

[0094] Table 3 Content of each component at different extraction ratios (μg / mL)

[0095]

[0096] 3.5 Chromatograms at different measurement wavelengths

[0097] Chromatographic conditions: CAPCELLPAK C 18 MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid aqueous solution (B), gradient elution (0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A); flow rate: 0.8 mL min -1; Column temperature 30℃; Injection volume 10μL; The chromatographic behavior of the test solution was investigated at detection wavelengths of 203nm, 250nm, and 280nm respectively.

[0098] Preparation of test solution: Prepare as in item "2".

[0099] like Figure 5 As shown in the figure, the test solution has the effect of terminal absorption at 203nm wavelength, and the baseline of the chromatographic peak is unstable and fluctuates greatly; when the detection wavelength is 280nm, the baseline is relatively straight, but there is a chromatographic peak with a very high response value at the retention time of about 9min, which seriously interferes with other chromatographic peaks; when the detection wavelength is 250nm, the baseline is straight and stable, the chromatographic information is rich, and the separation of each chromatographic peak is good. Therefore, 250nm was finally determined as the best detection wavelength.

[0100] The invention investigates the mobile phase system: 90% acetonitrile-water (containing 0.1% phosphoric acid), acetonitrile-water (containing 0.1% phosphoric acid), acetonitrile-water (containing 0.1% glacial acetic acid); extraction solvents: 30% methanol, 50% methanol, 70% methanol, 100% methanol, 95% ethanol and water; extraction ratio (sample: water are 1:0.5, 1:1, 1:2 respectively), and finally determines 250nm as the detection wavelength through repeated exploration combined with saving time and reagent cost, the mobile phase is acetonitrile-water (containing 0.1% phosphoric acid) gradient elution 117min, the extraction method is sample and water in a ratio of 1:1, ultrasonic extraction for 30min as the extraction conditions, when the chromatographic peaks of each component are better, the peak time is stable, and the chemical information of Huangqi Shengmai Drink can be reflected more comprehensively and accurately.

[0101] Example 2: A method for establishing an HPLC fingerprint of Huangqi Shengmai Yin

[0102] 1. Solution Preparation

[0103] 1.1 Preparation of reference solution

[0104] Accurately weigh an appropriate amount of each reference substance, place it in a 10 mL volumetric flask, dissolve it with methanol, and adjust the volume to obtain the mass concentrations of calycosin glucoside, codonopsis pilosula, formononetin, calycosin, formononetin, schisandrin A, and schisandrin B, which are 1.0813, 0.9036, 1.2799, 1.0786, 1.0818, 0.9510, and 1.0898 mg·mL, respectively. -1 , store at 4°C until use.

[0105] 1.2 Preparation of test solution

[0106] Accurately measure the sample (Y9) and mix it with water in a ratio of 1:1, perform ultrasonic extraction for 30 minutes, let it stand and cool, filter through a 0.45 μm microporous filter membrane, and obtain the filtrate.

[0107] 1.3 Preparation of negative sample solution

[0108] According to the prescription ratio, ultrasonic extraction with methanol for 30 minutes was performed to obtain negative samples lacking astragalus, codonopsis, schisandra, schisandra chinensis, schisandra chinensis and schisandra chinensis, or lacking all four ingredients at the same time. The samples were allowed to stand and cool, centrifuged, and the filtrate was taken to obtain the negative samples.

[0109] 2. Chromatographic conditions

[0110] Through the above optimization, the chromatographic conditions were determined to be: CAPCELLPAK C 18 MG chromatographic column (250 mm × 4.6 mm, 5 μm); mobile phase: acetonitrile (A)-0.1% phosphoric acid water (B), gradient elution (0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A); flow rate: 0.8 mL min -1 ; Column temperature 30℃; Detection wavelength 250nm; Injection volume 10μL.

[0111] 3. HPLC fingerprint study

[0112] 3.1 Methodological investigation

[0113] Take Huangqi Shengmai Yin sample (Y9), prepare the test solution according to the method in "1.2", and inject the sample under the chromatographic conditions under "2". Take peak 12 (calycosin isoflavone glucoside) as the reference, and measure the relative retention time and relative peak area RSD values ​​of 19 common peaks as shown in Table 4. Precision test: inject the sample 6 times continuously, and the results show that the instrument has good precision; stability test: inject the sample at 0, 2, 4, 8, 12, and 24h, and the results show that the prepared solution has good stability within 24h; repeatability: prepare 6 test solutions in parallel, and the injection results show that the method has good repeatability.

[0114] Table 4 Relative retention time and relative peak area RSD (%) common peaks

[0115]

[0116] 3.2 Graph generation and similarity analysis

[0117] Take the collected 20 batches of samples, prepare 2 copies in parallel according to the method in "1.2", perform sample injection and detection according to the chromatographic conditions in "2", and record the chromatograms. Import the chromatograms of 20 batches of Huangqi Shengmai Yin into the 2012 edition of "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System" for processing, use Y7 as the reference, the time window is 0.10, and perform mark peak matching after multi-point correction. The superimposed fingerprints and reference spectra (R) of 20 batches of Huangqi Shengmai Yin are calculated by the average.

[0118] like Figure 6 As shown, a total of 19 common peaks were calibrated for 20 batches of samples, identifying calycosin glucoside (peak 12), codonopsis pilosula glycoside (peak 14), formononetin (peak 15), calycosin (peak 16), formononetin (peak 17), schisandrin A (peak 18), and schisandrin B (peak 19). The similarity results of the fingerprints of each sample compared with the control fingerprint were 0.987, 0.945, 0.946, 0.913, 0.906, 0.896, 0.896, 0.997, 0.984, 0.911, 0.952, 0.961, 0.958, 0.999, 0.999, 0.940, 0.919, 0.936, 0.952, 0.932, and the similarity was between 0.896 and 0.999, indicating that the similarity between the batches was good.

[0119] 3.3 Chemometric analysis

[0120] 3.3.1 Cluster analysis

[0121] In this study, cluster analysis was performed on the 19 common peaks identified in the fingerprint of Huangqi Shengmai Decoction, and the common peak area was used as the variable. SPSS27.0 software was used to analyze the clusters using the inter-group linkage method and the Euclidean square distance. The results are shown in Table 2. Figure 7 When the class interval (d) is 10, the samples are divided into 4 categories. The first category is S2 manufacturer (Y14-Y20); the second category is Y1-Y6, Y8, Y9, Y11-Y13; the third category is Y10; and the fourth category is Y7. This shows that different batches of Huangqi Shengmai Yin from the same manufacturer have certain similarities.

[0122] 3.3.2 Principal Component Analysis

[0123] The peak areas of the 19 common peaks of 20 batches of Huangqi Shengmai Yin were imported into SPSS27.0 software for standardization and analysis, and the variance contribution rate and matrix eigenvalue were calculated. Five principal component factors with eigenvalues ​​greater than 1 were extracted, as shown in Table 5. The cumulative variance contribution rate was 90.367%, indicating that most of the information of the 19 common peaks in the fingerprint spectrum can be represented. The scree plot is shown in Figure 8As shown in Table 6, the factor loading matrix reflects the contribution rate of the 19 common peaks to each principal component. The greater the absolute value of the correlation coefficient, the greater its contribution to the principal component. Peaks 4, 12-16, 18, and 19 contribute more to the first principal component, peaks 8 and 11 contribute more to the second principal component, peaks 1 and 10 contribute more to the third principal component, peak 6 contributes more to the fourth principal component, and peak 17 contributes more to the fifth principal component.

[0124] Table 5 Principal component eigenvalues ​​and contribution rates

[0125]

[0126]

[0127] Table 6 Common peak component matrix

[0128]

[0129] 3.3.3 Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA)

[0130] Data analysis was performed using SIMCA14.1 software, with the peak area of ​​each common peak as the dependent variable and different batches as the independent variable. In the OPLS-DA model, the independent variable fit index (R 2 X) is 0.761 and the dependent variable fit index (R 2 Y) is 0.986, and the cumulative prediction degree (Q 2 ) is 0.953. The OPLS-DA score diagram is shown in Fig. 9 , which can effectively distinguish Huangqi Shengmai Yin from different manufacturers. The results of the variable importance in projection (VIP) analysis of each common peak are shown in Fig.10 , and the differential components were screened out with VIP>1. Results There were 9 common peaks with VIP value>1, namely peak 19 (schisandrin B), peak 18 (schisandrin A), peak 13, peak 4, peak 14 (codonopsis ginsenoside), peak 15 (formononetin), peak 12 (calycosin glucoside), peak 5 and peak 3. The components corresponding to these common peaks may be the differential components that affect the quality of Huangqi Shengmai Yin.

[0131] 4. Content Determination

[0132] 4.1 Specificity test

[0133] Take the reference substance, test substance, and negative sample solution under item "1", and perform the injection and determination according to the chromatographic conditions listed in "2".

[0134] Results Fig.11, it can be seen that the separation of each component is good, and in the negative chromatogram, each chromatographic peak only appears in the corresponding sample.

[0135] 4.2 Investigation of linear relationship

[0136] Accurately pipette 0.4mL of the reference solution of calycosin glucoside, 0.5mL of codonopsis ginsenoside, 0.1mL of formononetin, 0.1mL of calycosin, 0.05mL of formononetin, 0.5mL of schisandrae alcohol A, and 0.1mL of schisandrae alcohol B under item "1", place them in a 10mL volumetric flask, dilute to the mark with methanol, shake well, and prepare a mixed reference solution. Dilute step by step to a series of mass concentrations, and inject and measure according to the chromatographic conditions in "2". With the injection concentration as the horizontal axis (X) and the peak area as the vertical axis (Y), linear regression is performed as shown in Table 7. Each component has a good correlation in its respective interval.

[0137] Table 7 Linear relationship of each component

[0138]

[0139] 4.3 Precision test

[0140] Take an appropriate amount of the mixed reference solution under item "1" and inject and measure 6 times according to the chromatographic conditions in "2". The RSDs of the peak areas of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A and schisandrin B were 1.71%, 0.05%, 0.36%, 0.31%, 0.23%, 0.18% and 0.23%, respectively, indicating that the instrument has good precision.

[0141] 4.4 Repeatability test

[0142] Take the same batch of samples (Y9) and prepare 6 test solutions in parallel according to the method under "1". The samples were injected and determined according to the chromatographic conditions in "2". The peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A and schisandrin B were 0.21%, 2.52%, 2.12%, 1.84%, 2.78%, 0.84% ​​and 1.99%, respectively, and the average contents were 11.4508, 2.6211, 3.6856, 0.7202, 13.2208, 13.3957 and 2.6682 μg mL -1 , indicating that this method has good repeatability.

[0143] 4.5 Stability test

[0144] Take the same batch of samples (Y9) and prepare the test solution according to the method under "1.2". The samples were injected and measured according to the chromatographic conditions in "4" at 0, 2, 4, 8, 12, and 24 hours. The RSDs of the peak areas of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A, and schisandrin B were 0.29%, 1.11%, 2.15%, 2.54%, 1.54%, 0.23%, and 1.94%, respectively, indicating that the test solution had good stability within 24 hours.

[0145] 4.6 Sample recovery experiment

[0146] Take 9 samples from the same batch (Y9), accurately pipette 1.0 mL into each sample and randomly divide them into 3 groups. In each group, 50%, 100% and 150% of the known content of each component are accurately added with the reference solution (the mass concentrations of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis ginsenoside, schisandrae alcohol A and schisandrae alcohol B are 1.0813, 1.0786, 1.2799, 1.0818, 0.9036, 0.9510 and 1.0898 mg·mL, respectively). -1 ), sample injection was carried out according to the chromatographic conditions in "4", and the recovery rate was calculated. As a result, the average recovery rates of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis ginsenoside, schisandrae alcohol A, and schisandrae alcohol B were 99.47%, 105.43%, 95.17%, 103.50%, 94.10%, 92.57%, and 96.78%, respectively, and the RSDs were 2.59%, 2.50%, 3.19%, 2.93%, 2.94%, 2.00%, and 3.15%, respectively.

[0147] 4.7 Sample content determination

[0148] Take 20 batches of samples, 2 portions in each batch, prepare the test solution according to the method under "2.2", inject and measure according to the chromatographic conditions in "4", and calculate the content by external standard method. The results are shown in Table 8.

[0149] Table 8 Determination results of the content of each component (μg·mL -1 ,n=2)

[0150]

[0151] In summary, the present invention provides an HPLC multi-component content determination method for Huangqi Shengmai Drink. Through repeated exploration combined with saving time and reagent costs, 250nm was finally determined as the detection wavelength, the mobile phase was acetonitrile-water (containing 0.1% phosphoric acid), and the gradient elution was 117min; the extraction method was a 1:1 mixing of the sample and water, and ultrasonic extraction for 30min as the extraction conditions. The chromatographic peaks of each component had better peak shapes and stable peak times, which could more comprehensively and accurately reflect the chemical information of Huangqi Shengmai Drink. Specificity test: the separation of each component is good. In the negative chromatogram, each chromatographic peak only appears in the corresponding sample. Linear relationship: each component has a good correlation in its own interval. Precision test: after 6 consecutive injections, the RSDs of the peak areas of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis ginsenoside, schisandrin A and schisandrin B were 1.71%, 0.05%, 0.36%, 0.31%, 0.23%, 0.18% and 0.23%, respectively, indicating that the instrument precision is good. Good; Repeatability: 6 test solutions were prepared in parallel, and the peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A, and schisandrin B were 0.21%, 2.52%, 2.12%, 1.84%, 2.78%, 0.84%, and 1.99%, respectively, and the average contents were 11.4508, 2.6211, 3.6856, 0.7202, 13.2208, 13.3957, and 2.6682 μg·mL -1, indicating that the method has good repeatability; stability test: the sample was injected and measured at 0, 2, 4, 8, 12, and 24 hours, and the peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A, and schisandrin B were 0.29%, 1.11%, 2.15%, 2.54%, 1.54%, 0.23%, and 1.94%, respectively, indicating that the test solution had good stability within 24 hours; the sample was injected and measured at 0, 2, 4, 8, 12, and 24 hours, and the peak area RSDs of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis pilosula, schisandrin A, and schisandrin B were 0.29%, 1.11%, 2.15%, 2.54%, 1.54%, 0.23%, and 1.94%, respectively. Yield test: The average recoveries of calycosin glucoside, calycosin, formononetin, formononetin, codonopsis glycoside, schisandra alcohol A and schisandra alcohol B were 99.47%, 105.43%, 95.17%, 103.50%, 94.10%, 92.57% and 96.78%, respectively, and the RSDs were 2.59%, 2.50%, 3.19%, 2.93%, 2.94%, 2.00% and 3.15%, respectively. The results of the present invention showed that in the fingerprint evaluation of 20 batches of Huangqi Shengmai Yin, the similarity was between 0.896 and 0.999, indicating that the chemical composition of each batch of Huangqi Shengmai Yin was similar, but there were certain differences in the content of each component, which required further analysis and verification. In cluster analysis, Huangqi Shengmai Yin was divided into 4 categories, samples from manufacturer S2 were clustered into the first category, 11 batches of samples from manufacturer S1 were clustered into the second category, and the remaining 2 batches of samples were clustered into the third and fourth categories respectively. A total of 5 principal components were extracted by principal component analysis, and the cumulative variance contribution rate was 90.367%. There were 9 common peaks with VIP values ​​greater than 1 in the partial least squares discriminant analysis results, and these components may be differential components that affect the quality of Huangqi Shengmai Yin. The present invention establishes an HPLC fingerprint of Huangqi Shengmai Yin, which has strong specificity, is accurate and reliable, and has a simple pre-treatment of the test solution. According to the principle of "component measurability" of Q-Marker, it provides a reference basis for comprehensive evaluation of the effective quality control of Huangqi Shengmai Yin, and can be used to control the quality of Huangqi Shengmai Yin.

Claims

1. A HPLC detection method for Huangqi Shengmai Yin, characterized in that: After appropriate extraction of Huangqi Shengmai Decoction, the test solution was prepared, and the test solution was determined by HPLC; the HPLC test conditions were: Column: CAPCELLPAK C 18 MG column, 250 mm × 4.6 mm, 5 μm; Mobile phase: phase A is acetonitrile, phase B is 0.1% phosphoric acid aqueous solution, gradient elution; Flow rate: 0.8 mL•min -1 ; Column temperature: 30°C; Detection wavelength 203~280nm; Injection volume: 10 μL; The specific process of gradient elution is as follows: 0-10 min, 3% A; 10-20 min, 3%-6% A; 20-30 min, 6%-12% A; 30-36 min, 12% A-16% A; 36-56 min, 16%-21% A; 56-76 min, 21%-27% A; 76-87 min, 27%-37% A; 87-97 min, 37%-60% A; 97-105 min, 60%-79% A; 105-113 min, 79%-91% A; 113-117 min, 91%-1% A; Preparation of test solution: accurately measure Huangqi Shengmai Yin and mix it with water in a ratio of 1:1, perform ultrasonic extraction for 30 minutes, let it stand and cool, filter it with a 0.45 μm microporous membrane, and take the filtrate to obtain the solution; Preparation of reference solution: Accurately weigh an appropriate amount of each reference substance, place it into a 10 mL volumetric flask, dissolve it with methanol, and make up to volume to obtain the mass concentrations of calycosin glucoside, codonopsis pilosula, formononetin, calycosin, formononetin, schisandra alcohol A, and schisandra alcohol B of 1.0813, 0.9036, 1.2799, 1.0786, 1.0818, 0.9510, and 1.0898 mg•mL-1, respectively. Store at 4°C for use.

2. The HPLC detection method according to claim 1, wherein The detection wavelength is 250nm.

3. A method for establishing the HPLC fingerprint of Huangqi Shengmai Yin, characterized in that: The method comprises the following steps: S1. Preparation of reference substance solution: accurately weigh each reference substance, place it in a volumetric flask, dissolve it with methanol, and make up to volume to obtain a reference substance solution containing a predetermined concentration of a standard component; S2. Preparation of test solution: accurately measure the sample, mix it with the extraction solvent at an extraction ratio of 1:0.5~2, perform ultrasonic extraction, let it stand and cool, filter, and take the filtrate to obtain the solution; S3, content determination: adopt the HPLC detection method described in claim 1 or 2 to obtain the reference chromatogram of the reference solution and the test chromatogram of the test solution respectively under the same chromatographic conditions; The standard components described in step S1 are calycosin glucoside, codonopsis pilosula, formononetin, calycosin, formononetin, schisandrin A and schisandrin B; and the extraction solvent described in step S2 is water.

4. The method for establishing the HPLC fingerprint of Huangqi Shengmai Yin according to claim 3, characterized in that: The extraction ratio of the test solution to the extraction solvent described in step S2 is 1:

1.

5. The method for establishing the HPLC fingerprint of Huangqi Shengmai Yin as claimed in claim 3, characterized in that: The filtration in step S2 uses a 0.45 μm microporous filter membrane.

6. Use of the method for establishing the HPLC fingerprint of Huangqi Shengmai Yin according to any one of claims 3 to 5 in detecting and identifying Huangqi Shengmai Yin.